IBL C3D-CIC EIA TEST— 510(k) K032796

Substantially Equivalent

Ibl GmbH

FDA 510(k) clearance K032796 for IBL C3D-CIC EIA TEST, Substantially Equivalent on 2004-01-13. Applicant: Ibl GmbH.

Clearance details

Applicant: Ibl GmbH
Product code: Code CZW
Advisory panel: Immunology
Date received: 2003-09-08
Decision date: 2004-01-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: East Stroudsburg, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.